A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Mathemycin A | It is produced by the strain of Act. sp. HIL Y-862O. It has an inhibitory effect on pathogenic fungi. It inhibits the Phytophthora infestans JO8 in vitro (MIC is 7.8 μg/mL), and it inhibits JO8 in greenhouse (LD50 is 42 X 10-6, LC90 is 500 X 10-6). Molecular formula: C71H132N2O24. Mole weight: 1397.80. |  |
| Mathemycin B | It is produced by the strain of Act. sp. HIL Y-862O. It has an inhibitory effect on pathogenic fungi. It inhibits the Phytophthora infestans JO8 in vitro (MIC is 7.8 μg/mL), and it inhibits JO8 in greenhouse (LD50 is 42 X 10-6, LC90 is 500 X 10-6). Molecular formula: C77H142N2O29. Mole weight: 1559.94. | |
| Matlystatin A | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 0.3 and 1.2, respectively. It has anti-gram-positive bacteria effect. Synonyms: N-Acetyl-S-(4-(((hexahydro-2-(2-(2-(hydroxyamino)-2-oxoethyl)-1-oxoheptyl)-3-pyridazinyl)carbonyl)amino)-5-methyl-3-oxoheptyl)-L-cysteine; N-acetyl-S-(4-(2-(2-(2-(hydroxyamino)-2-oxoethyl)heptanoyl)hexahydropyridazine-3-carboxamido)-5-methyl-3-oxoheptyl)-L-cysteine. CAS No. 140626-94-4. Molecular formula: C27H47N5O8S. Mole weight: 601.76. | |
| Matlystatin B | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 1.43 and 1.2, respectively. It has anti-gram-positive bacteria effect. Synonyms: 1(2H)-Pyridazinebutanamide, tetrahydro-N-hydroxy-6-[[[2-methyl-1-(1-oxopropyl)butyl]amino]carbonyl]-g-oxo-b-pentyl-, [6S-[1(S*),6R*(1R*,2R*)]]-; Matlystatin B1. CAS No. 140923-32-6. Molecular formula: C22H40N4O5. Mole weight: 440.58. | |
| Matlystatin D | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 3.64 and 28, respectively. Synonyms: Matlystatin D1; Pyrazolo(1,2-a)pyridazin-4-ium,8-carboxy-1-(1-(((hexahydro-2-(2-(2-(hydroyamino)-2-oxoethyl)-1-oxoheptyl)-3-pyridazinyl)carbonyl)amino)-2-methylbutyl)-5,6,7,8-tetrahydro-,hydroxide,inner salt; [(3-{6-[{[1-(8-Carboxy-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-9-ium-1-yl)-2-methylbutyl]imino}(hydroxy)methyl]-1,2-diazinane-1-carbonyl}-1-hydroxyoctylidene)amino]oxidanide. CAS No. 140638-25-1. Molecular formula: C27H44N6O6. Mole weight: 548.68. | |
| Matlystatin E | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 19.3 and 59, respectively. Synonyms: Matlystatin E1; Pyrazolo(1,2-a)pyridazin-4-ium,8-carboxy-1-(1-(((hexahydro-2-(2-(2-(hydroxyamino)-2-oxoethyl)-1-oxohexyl)-3-pyridazinyl)carbonyl)amino)-2-methylbutyl)-5,6,7,8-tetrahydro-,hydroxide,inner salt; [(3-{6-[{[1-(8-Carboxy-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-9-ium-1-yl)-2-methylbutyl]imino}(hydroxy)methyl]-1,2-diazinane-1-carbonyl}-1-hydroxyheptylidene)amino]oxidanide. CAS No. 140638-26-2. Molecular formula: C26H42N6O6. Mole weight: 534.65. | |
| Matlystatin F | It is produced by the strain of Actinomadura atramentaria. It's a Type V collagenase inhibitor. It can inhibit type IV collagenase and type I collagenase with ID50 (μmol/L) of 1.82 and 5.1, respectively. Synonyms: Matlystatin F1; Pyrazolo(1,2-a)pyridazin-4-ium,5-carboxy-1-(1-(((hexahydro-2-(2-(2-(hydroyamino)-2-oxoethyl)-1-oxoheptyl)-3-pyridazinyl)carbonyl)amino)-2-methylbutyl)-5,6,7,8-tetrahydro-,hydroxide,inner salt; [(3-{6-[{[1-(5-Carboxy-5,6,7,8-tetrahydropyrazolo[1,2-a]pyridazin-9-ium-1-yl)-2-methylbutyl]imino}(hydroxy)methyl]-1,2-diazinane-1-carbonyl}-1-hydroxyoctylidene)amino]oxidanide. CAS No. 140667-42-1. Molecular formula: C27H44N6O6. Mole weight: 548.68. | |
| matrilysin | Found in rat uterus; at 19 kDa, the smallest member of peptidase family M10 (interstitial collagenase family). Similar in specificity to stromelysin, but more active on azocoll. Group: Enzymes. Synonyms: matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Enzyme Commission Number: EC 3.4.24.23. CAS No. 141256-52-2. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4304; matrilysin; EC 3.4.24.23; 141256-52-2; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Cat No: EXWM-4304. |  |
| Matrilysin (96-107) | Matrilysin (MAT) is a member of the matrix metalloproteinase (MMP) family which is believed to degrade components of the extracellular matrix (ECM) during processes of tissue remodeling. Synonyms: MMP7 (96-107). | |
| Matrine | Matrine. Group: Biochemicals. Alternative Names: Sophoridine. Grades: Plant Grade. CAS No. 519-02-8. Pack Sizes: 20mg. Molecular Formula: C15H24N2O, Molecular Weight: 248.364. US Biological Life Sciences. |  Worldwide |
| Matrine | Matrine ((+)-Matrine) is an alkaloid found in plants from the Sophora family, which has a variety of pharmacological effects, including anti-cancer effects, and action as a kappa opioid receptor agonist. Uses: Anticancer. Synonyms: Matridin-15-one; Matrine; NSC 146051; NSC146051; NSC-146051. Grade: >98%. CAS No. 519-02-8. Molecular formula: C15H24N2O. Mole weight: 248.36. | |
| Matrine | Matrine (Matridin-15-one) is an alkaloid found in plants from the Sophora genus that can act as a kappa opioid receptor and u-receptor agonist. Matrine has a variety of pharmacological effects, including anti-cancer, anti-oxidative stress, anti-inflammation and anti-apoptosis effects. Matrine is potential in the research of disease like human non-small cell lung cancer, hepatoma, papillary thyroid cancer and acute kidney injury (AKI)[1][2][3][4][5]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: Matridin-15-one; Vegard; α-Matrine. CAS No. 519-02-8. Pack Sizes: 10 mM * 1 mL in DMSO; 100 mg; 200 mg; 500 mg. Product ID: HY-N0164. |  |
| matriptase | This trypsin-like integral-membrane serine peptidase has been implicated in breast cancer invasion and metastasis. The enzyme can activate hepatocyte growth factor/scattering factor (HGF/SF) by cleavage of the two-chain form at an Arg residue to give active α- and β-HGF, but It does not activate plasminogen, which shares high homology with HGF.The enzyme can also activate urokinase plasminogen activator (uPA), which initiates the matrix-degrading peptidase cascade. Belongs in peptidase family S1A. Group: Enzymes. Synonyms: serine protease 14; membrane-type serine protease 1; MT-SP1; prostamin; serine protease TADG-15; tumor-associated differentially-expressed gene 15 protein; ST14; breast cancer 80 kDa protease; epithin; serine endopeptidase SNC19. Enzyme Commission Number: EC 3.4.21.109. CAS No. 241475-96-7. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-4104; matriptase; EC 3.4.21.109; 241475-96-7; serine protease 14; membrane-type serine protease 1; MT-SP1; prostamin; serine protease TADG-15; tumor-associated differentially-expressed gene 15 protein; ST14; breast cancer 80 kDa protease; epithin; serine endopeptidase SNC19. Cat No: EXWM-4104. | |
| Matriptase-2 from Human, Recombinant | Matriptase-2 (TMPRSS6) is a type II transmembrane serine protease mainly produced by the liver. It acts as a potent negative regulator of hepcidin, a hepatic peptide hormone and integral player in regulating iron homeostasis. Group: Enzymes. Synonyms: Transmembrane protease serine 6; TMPRSS6; Matriptase-2. Enzyme Commission Number: EC 3.4.21.-. Purity: Purified by multi-step chromatography. Matriptase-2. Mole weight: ~84 kDa; a-subunit: ~56kDa; b-subunit: ~28kDa. Activity: ~2.5U/ul. Stability: Stable for at least 6 months when stored at -20°C. Recommended Assay Buffer: 100mM TRIS, pH 9.0, containing 0.5mg/ml BSA. Do not store diluted solutions. Storage: Short Term Storage: -20°C; Long Term Storage: -80°C. Form: Liquid. In 100mM TRIS-HCl, pH 9.0, containing 150 mM sodium chloride and 20% glycerol. Source: Drosophila Schneider 2 (S2) cells. Species: Human. Transmembrane protease serine 6; TMPRSS6; Matriptase-2. Cat No: NATE-0857. | |
| Matrix Metalloproteinase-13 (HisoTag) from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular pr., a ca2+- and zn2+- binding catalytic domain, a hinge region, and a c-terminal hemopexin domain. hydrolyzes collagen type ii 5-6 times faster than collagens type i and iii. exhibits high activity towards gelatin and degrades α1-antichymotrypsin and plasminogen activator inhibitor-2. Group: Enzymes. Synonyms: Collagenase-3; Matrix metallopeptidase 13; MMP13; CLG3; MANDP1; MMP-13. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 60 kDa. Activity: >50 mU/mg protein. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: S. frugiperda. Species: Human. Collagenase-3; Matrix metallopeptidase 13; MMP13; CLG3; MANDP1; MMP-13. Cat No: NATE-0859. | |
| Matrix Metalloproteinase-1 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe.may also undergo autocatalysis to yield a 27 kda/22 kda active enzyme. expressed by a large number of cell types. cleaves fibrillar type i collagen. must be activated just prior to use. Group: Enzymes. Synonyms: Matrix Metalloproteinase 1; Human Interstitial Collagenase; Collagenase-1; EC 3.4.24.7; vertebrate collagenase. Enzyme Commission Number: EC 3.4.24.7. CAS No. 9001-12-1. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 56 kDa/52 kDa. Activity: >15 mU/mg protein. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: Human Rheumatoid Synovial Fibroblast. Species: Human. Matrix Metalloproteinase 1; Human Interstitial Collagenase; Collagenase. | |
| Matrix Metalloproteinase-2 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe. does not interfere with activation. may contain up to 10% timp proteins. during storage, a small portion (less than 10%) of the enzyme may also become activated. Group: Enzymes. Synonyms: 72 kDa Gelatinase; Matrix Metalloproteinase 2; Gelatinase A; EC 3.4.24.24; type IV collagenase; 3/4 collagenase; matrix metalloproteinase 5; 72 kDa gelatinase type A; collagenase IV; collagenase type IV; MMP 2; type IV collagen metalloproteinase; type IV collagenase/gelatinase. Enzyme Commission Number: EC 3.4.24.24. CAS No. 146480-35-5. Purity: >90% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 72 kDa. Storage: < -70°C; Avoid freeze/thaw. Form: Liquid. Source: CHO Cells. Spe. | |
| Matrix Metalloproteinase-3 from Human, Recombinant | Matrix metalloproteinase-3 (MMP-3) also known as stromelysin-1 and transin (EC 3.4.24.17) cleaves a number of substrates including cartilage proteoglycan, collagen types II, III, IV, V and IX, fibronectin, laminin, and can activate MMP 1. MMP-3 is secreted as 57 and 59 kDa proenzymes and can be activated in vitro by organomercurials (e.g., 4 aminophenylmercuric acetate, APMA) and in vivo by proteases via intermediate forms to a 45 kDa active MMP 3 enzyme. Further autolysis to a 28 kDa form can also occur. MMP-3 is thought to play an important role in pathophysiological degradation processes associated with conditions such as rheumatoid arthritis and cancer cell invas.C 3.4.24.17; matrix metalloproteinase 3; proteoglycanase; collagenase activating protein; procollagenase activator; transin; MMP-3; neutral proteoglycanase; stromelysin; collagen-activating protein. Enzyme Commission Number: EC 3.4.24.17. CAS No. 79955-99-0. Purity: >95% by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 57 kDa. Storage: < -70°C; Avoid freeze/thaw. Form: Lyophilized from 100 mM NaCl, 50 mM HEPES, pH 7.3. Species: Human. Stromelysin 1; EC 3.4.24.17; matrix metalloproteinase 3; proteoglycanase; collagenase activating protein; procollagenase activator; transin; MMP-3; neutral proteoglycanase; stromelysin; collagen-activating protein. Cat No: NATE-0861. | |
| Matrix Metalloproteinase-7 from human, Recombinant | MMP-7 degrades general matrix components and may have a role in processes such as host defense, cell proliferation, and protein turnover as well as tissue remodeling. Group: Enzymes. Synonyms: MMP7; matrix metallopeptidase 7; MMP-7; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. CAS No. 141256-52-2. Matrix Metalloproteinase. Storage: -70°C. Form: buffered aqueous solution, Supplied in a buffer containing the active enzyme in 10 mM HEPES, pH 7.4, 0.15 M sodium chloride, 5 mM calcium chloride. Source: E. coli. Species: Human. MMP7; matrix metallopeptidase 7; MMP-7; matrin; uterine metalloendopeptidase; matrix metalloproteinase 7; putative (or punctuated) metalloproteinase-1; matrix metalloproteinase pump 1; MMP 7; PUMP-1 proteinase; PUMP; metalloproteinase pump-1; putative metalloproteinase; MMP. Cat No: NATE-0451. | |
| Matrix Metalloproteinase-8 from Human, Recombinant | Full-length recombinant human neutrophil pro-collagenase (MMP-8), latent form. Matrix metalloproteinase 8 (MMP-8), or neutrophil collagenase, degrades interstitial collagens, acting preferentially on collagen type I. Increased full-length MMP-8 protein was associated with infiltration into the skin of neutrophils, which are the major cell type that expresses MMP-8. MMP-8 is synthesized and stored in specific granules in neutrophil leukocytes. MMP-8 activity is therefore regulated by factors such as surface-bound ligands (IgG or complement components) that release it through degranulation.Once released and activated through proteolytic or oxidative mechanisms, MMP-8 p.ollagenase activity. Group: Enzymes. Synonyms: Neutrophil collagenase; EC 3.4.24.34; Matrix metalloproteinase-8; MMP-8; PMNL collagenase; PMNL-CL; HNC; CLG1. Enzyme Commission Number: EC 3.4.24.34. CAS No. 9001-12-1. Purity: Greater than 90% as determined by SDS-PAGE. Matrix Metalloproteinase. Mole weight: 75 kDa. Activity: 100 units/ml. Stability: MMP-8 although stable at 4°C for 1 week, should be stored desiccated below -18°C. Please prevent freeze-thaw cycles. Appearance: Sterile Filtered clear solution. Source: E. coli. Species: Human. Neutrophil collagenase; EC 3.4.24.34; Matrix metalloproteinase-8; MMP-8; PMNL collagenase; PMNL-CL; HNC; CLG1. Cat No: NATE-0862. | |
| Matrix Metalloproteinase-9 from Human, Recombinant | Matrix metalloproteinases are members of a unique family of proteolytic enzymes that have a zinc ion at their active sites and can degrade collagens, elastin and other components of the extracellular matrix (ECM). These enzymes are present in normal healthy individuals and have been shown to have an important role in processes such as wound healing, pregnancy, and bone resorption. However, overexpression and activation of MMPs have been linked with a range of pathological processes and disease states involved in the breakdown and remodeling of the ECM. Such diseases include tumor invasion and metastasis, rheumatoid arthritis, periodontal disease and vascular processe.(less than 10%) of the enzyme may also become activated. requires activation prior to use. a simple activation protocol is included. Applications: Immunoblotting (1 ug protein/lane) substrate cleavage assay (1 ug protein/lane) zymography (1 ug protein/lane). Group: Enzymes. Synonyms: Gelatinase B; EC 3.4.24.35; 92-kDa gelatinase; matrix metalloproteinase 9; type V collagenase; 92-kDa type IV collagenase; macrophage gelatinase; 95 kDa type IV collagenase/gelatinase; collagenase IV; collagenase type IV; gelatinase MMP 9; MMP 9; type IV collagen metalloproteinase. Enzyme Commission Number: EC 3.4.24.35. CAS No. 146480-36-6. Purity: >90% by SDS-PAGE. Matrix Metalloprotei. | |
| Matrix protein 1 (229-237) | Matrix protein 1 (229-237) is a peptide derived from M1, a matrix protein of the influenza virus. And it is associated with Human respiratory syncytial virus and lung carcinoma. Synonyms: M1 (229-237). | |
| Matrix protein 1 (27-35) | Matrix protein 1 (27-35) is a peptide derived from M1, a matrix protein of the influenza virus. And it is associated with Influenza A virus and lung carcinoma. Synonyms: M1 (27-35). | |
| Matrix Protein M1 (58-66) (Influenza A virus) | It is the epitope of influenza A virus matrix protein. Synonyms: Matrix protein 1 (58-66); FLUM1 A2 peptide (58-66); CEF1, Influenza Matrix Protein M1 58-66; Gly-Ile-Leu-Gly-Phe-Val-Phe-Thr-Leu; glycyl-L-isoleucyl-L-leucyl-glycyl-L-phenylalanyl-L-valyl-L-phenylalanyl-L-threonyl-L-leucine. Grade: ≥95%. CAS No. 141368-69-6. Molecular formula: C49H75N9O11. Mole weight: 966.17. | |
| Matrixyl 3000 | Matrixyl 3000 is an anti-aging ingredient developed by Sederma. Matrixyl 3000 is a combination of palmitoyl oligopeptide and palmitoyl tetrapeptide-7. Grade: 98%. | |
| Matrixyl 3000-Palmitoyl Oligopeptide+Palmitoyl Tetrapeptide-7 | Matrixyl 3000-Palmitoyl Oligopeptide+Palmitoyl Tetrapeptide-7. Product ID: CI-BP-0041. Alfa Chemistry - ISO 9001:32057 Certified. |  |
| Matrixyl / Palmitoyl Pentapeptide-3/4 (Pal-KTTKS) | Matrixyl / Palmitoyl Pentapeptide-3/4 (Pal-KTTKS). CAS No. 214047-00-4. Product ID: CDC10-0665. Category: Cosmetic Active Peptide. Product Keywords: Cosmetic Ingredients; Active Ingredients; Cosmetic Active Peptide; ; CDC10-0665; Matrixyl / Palmitoyl Pentapeptide-3/4 (Pal-KTTKS); Cosmetic Active Peptide; ; 214047-00-4. Purity: 98%/99%. Applications: For collagen synthesis, repair the damaged skin and anti-aging. |  |
| Mattiflux Flux Powder | Mattiflux Flux Powder. |  |
| Matuzumab | Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth. Deglycosylation and the possible elimination of ADCC activity can reduce the in vivo anti-tumor activity of Mattuzumab[1]. Uses: Scientific research. Category: Signaling pathways. Alternative Names: EMD 72000. CAS No. 339186-68-4. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P9969. | |
| Mauritianin | Mauritianin. Group: Biochemicals. CAS No. 109008-28-8. Pack Sizes: 5mg. US Biological Life Sciences. | Worldwide |
| Mauritianin | Mauritianin is a compound of the flavonoid class found in the herbs of Hypericum japonicum Thunb. Mauritianin is a topoisomerase I inhibitor. Synonyms: 5,7-dihydroxy-3-[(2R,3R,4S,5S,6R)-5-hydroxy-6-(hydroxymethyl)-3,4-bis[[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy]oxan-2-yl]oxy-2-(4-hydroxyphenyl)chromen-4-one. Grade: >98%. CAS No. 109008-28-8. Molecular formula: C33H40O19. Mole weight: 740.664. | |
| Maurocalcine | Maurocalcine is a highly potent cell-penetrating peptide isolated from the Tunisian scorpion Maurus palmatus. It is an activator of Ca2+ release channel and a Ryanodine receptors agonist. It is a 33-mer basic peptide cross-linked by three disulfide bridges. Synonyms: MCa. Grade: >97%. | |
| Mavacamten | Mavacamten (MYK461) is an orally active modulator of cardiac myosin, with IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MYK461; SAR439152. CAS No. 1642288-47-8. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-109037. | |
| Mavacamten-d5 | Mavacamten-d5 (MYK461-d5; SAR439152-d5) is deuterium labeled Mavacamten (HY-109037). Mavacamten (MYK461) is an orally active modulator of cardiac myosin, with IC50s of 490, 711 nM for bovine cardiac and human cardiac, respectively. Uses: Scientific research. Category: Signaling pathways. Alternative Names: MYK461-d5; SAR439152-d5. CAS No. 2453251-00-6. Pack Sizes: 10 mM * 1 mL in DMSO; 1 mg; 5 mg; 10 mg. Product ID: HY-109037S3. | |
| Mavacamten impurity 1 | Mavacamten impurity 1. Uses: For analytical and research use. Molecular formula: C12H14O7. Mole weight: 270.24. Catalog: APB12386. |  |
| Mavacamten impurity 10 | Mavacamten impurity 10. Uses: For analytical and research use. Molecular formula: C9H14N2O3. Mole weight: 198.22. Catalog: APB12382. | |
| Mavacamten impurity 11 | Mavacamten impurity 11. Uses: For analytical and research use. CAS No. 5759-79-5. Molecular formula: C12H13N3O2. Mole weight: 231.26. Catalog: APB5759795. | |
| Mavacamten impurity 12 | Mavacamten impurity 12. Uses: For analytical and research use. CAS No. 2704235-12-9. Molecular formula: C15H19N3O2. Mole weight: 273.34. Catalog: APB2704235129. | |
| Mavacamten impurity 13 | Mavacamten impurity 13. Uses: For analytical and research use. CAS No. 1642288-64-9. Molecular formula: C15H19N3O2. Mole weight: 273.34. Catalog: APB1642288649. | |
| Mavacamten impurity 14 | Mavacamten impurity 14. Uses: For analytical and research use. CAS No. 1642289-37-9. Molecular formula: C15H19N3O3. Mole weight: 289.34. Catalog: APB1642289379. | |
| Mavacamten impurity 15 | Mavacamten impurity 15. Uses: For analytical and research use. CAS No. 1642289-31-3. Molecular formula: C17H23N3O2. Mole weight: 301.39. Catalog: APB1642289313. | |
| Mavacamten impurity 16 | Mavacamten impurity 16. Uses: For analytical and research use. CAS No. 1642289-02-8. Molecular formula: C15H19N3O3. Mole weight: 289.34. Catalog: APB1642289028. | |
| Mavacamten impurity 17 | Mavacamten impurity 17. Uses: For analytical and research use. CAS No. 1642288-68-3. Molecular formula: C16H21N3O2. Mole weight: 287.36. Catalog: APB1642288683. | |
| Mavacamten impurity 18 | Mavacamten impurity 18. Uses: For analytical and research use. CAS No. 1642289-16-4. Molecular formula: C16H21N3O2. Mole weight: 287.36. Catalog: APB1642289164. | |
| Mavacamten impurity 19 | Mavacamten impurity 19. Uses: For analytical and research use. CAS No. 1642288-97-8. Molecular formula: C16H21N3O2. Mole weight: 287.36. Catalog: APB1642288978. | |
| Mavacamten impurity 2 | Mavacamten impurity 2. Uses: For analytical and research use. Molecular formula: C9H15N3O3. Mole weight: 213.24. Catalog: APB12383. | |
| Mavacamten impurity 20 | Mavacamten impurity 20. Uses: For analytical and research use. CAS No. 1642289-54-0. Molecular formula: C15H19N3O4. Mole weight: 305.33. Catalog: APB1642289540. | |
| Mavacamten impurity 21 | Mavacamten impurity 21. Uses: For analytical and research use. CAS No. 1642289-43-7. Molecular formula: C16H21N3O2. Mole weight: 287.36. Catalog: APB1642289437. | |
| Mavacamten impurity 22 | Mavacamten impurity 22. Uses: For analytical and research use. CAS No. 1642289-38-0. Molecular formula: C15H19N3O3. Mole weight: 289.34. Catalog: APB1642289380. | |
| Mavacamten impurity 23 | Mavacamten impurity 23. Uses: For analytical and research use. CAS No. 1642289-11-9. Molecular formula: C15H19N3O3. Mole weight: 289.34. Catalog: APB1642289119. | |
| Mavacamten impurity 24 | Mavacamten impurity 24. Uses: For analytical and research use. CAS No. 1642289-74-4. Molecular formula: C15H19N3O3. Mole weight: 289.34. Catalog: APB1642289744. | |
| Mavacamten impurity 25 | Mavacamten impurity 25. Uses: For analytical and research use. CAS No. 1642289-56-2. Molecular formula: C15H19N3O3. Mole weight: 289.34. Catalog: APB1642289562. | |
| Mavacamten impurity 26 | Mavacamten impurity 26. Uses: For analytical and research use. CAS No. 1642289-29-9. Molecular formula: C17H23N3O2. Mole weight: 301.39. Catalog: APB1642289299. | |
| Mavacamten impurity 27 | Mavacamten impurity 27. Uses: For analytical and research use. CAS No. 1642289-26-6. Molecular formula: C17H23N3O2. Mole weight: 301.39. Catalog: APB1642289266. | |
| Mavacamten impurity 28 | Mavacamten impurity 28. Uses: For analytical and research use. CAS No. 1642289-62-0. Molecular formula: C16H21N3O3. Mole weight: 303.36. Catalog: APB1642289620. | |
| Mavacamten impurity 29 | Mavacamten impurity 29. Uses: For analytical and research use. CAS No. 1642289-04-0. Molecular formula: C16H18N4O2. Mole weight: 298.35. Catalog: APB1642289040. | |
| Mavacamten impurity 3 | Mavacamten impurity 3. Uses: For analytical and research use. CAS No. 66400-12-2. Molecular formula: C10H16N2O3. Mole weight: 212.25. Catalog: APB66400122. | |
| Mavacamten impurity 30 | Mavacamten impurity 30. Uses: For analytical and research use. CAS No. 1642288-69-4. Molecular formula: C16H21N3O2. Mole weight: 287.36. Catalog: APB1642288694. | |
| Mavacamten impurity 31 | Mavacamten impurity 31. Uses: For analytical and research use. CAS No. 1642288-74-1. Molecular formula: C15H18FN3O2. Mole weight: 291.33. Catalog: APB1642288741. | |
| Mavacamten impurity 32 | Mavacamten impurity 32. Uses: For analytical and research use. CAS No. 1642288-66-1. Molecular formula: C16H21N3O3. Mole weight: 303.36. Catalog: APB1642288661. | |
| Mavacamten impurity 33 | Mavacamten impurity 33. Uses: For analytical and research use. CAS No. 1642288-65-0. Molecular formula: C16H21N3O3. Mole weight: 303.36. Catalog: APB1642288650. | |
| Mavacamten impurity 34 | Mavacamten impurity 34. Uses: For analytical and research use. CAS No. 1642288-60-5. Molecular formula: C17H23N3O3. Mole weight: 317.39. Catalog: APB1642288605. | |
| Mavacamten impurity 35 | Mavacamten impurity 35. Uses: For analytical and research use. CAS No. 1642289-94-8. Molecular formula: C15H18BrN3O2. Mole weight: 352.23. Catalog: APB1642289948. | |
| Mavacamten impurity 36 | Mavacamten impurity 36. Uses: For analytical and research use. CAS No. 1642289-61-9. Molecular formula: C15H18ClN3O2. Mole weight: 307.78. Catalog: APB1642289619. | |
| Mavacamten impurity 37 | Mavacamten impurity 37. Uses: For analytical and research use. CAS No. 1642288-79-6. Molecular formula: C15H18BrN3O2. Mole weight: 352.23. Catalog: APB1642288796. | |
| Mavacamten impurity 38 | Mavacamten impurity 38. Uses: For analytical and research use. CAS No. 1642288-72-9. Molecular formula: C15H18ClN3O2. Mole weight: 307.78. Catalog: APB1642288729. | |
| Mavacamten impurity 4 | Mavacamten impurity 4. Uses: For analytical and research use. CAS No. 67463-81-4. Molecular formula: C12H21N3O3. Mole weight: 255.32. Catalog: APB67463814. | |
| Mavacamten impurity 5 | Mavacamten impurity 5. Uses: For analytical and research use. Molecular formula: C14H17ClN4O4. Mole weight: 340.76. Catalog: APB12377. | |
| Mavacamten impurity 6 | Mavacamten impurity 6. Uses: For analytical and research use. Molecular formula: C14H18N4O5. Mole weight: 322.32. Catalog: APB12378. | |
| Mavacamten impurity 7 | Mavacamten impurity 7. Uses: For analytical and research use. Molecular formula: C10H16N2O3. Mole weight: 212.25. Catalog: APB12379. | |
Our database is helping our users find suppliers everyday.
